Headline News from The Associated Press
AP Headline News - Jul 03 2024 05:00 (EDT)
This is AP News, I'm Rita Falle. Hurricane barrels been moving toward Jamaica, a powerful Category 4 storm. At least six people have died after barrels slammed islands in the Southeast Caribbean. Here at home, it's the heat. Nearly 90 million Americans are under heat alerts. The National Weather Service is Brian Jackson. Some of your hotter places like Las Vegas and into the Center Valley, California, look to exceed 115 in places by Saturday. Brian Jackson, with the Weather Service, heat of another sword in Washington, where President Biden is signaling he does not intend to drop out of the race for the White House, despite that shaky debate performance. But now... Texas Congressman Lloyd Doggett is the first Democrat publicly calling for the President to step aside as nominee and former House Speaker Nancy Pelosi, tells MSNBC, asking about the President's halting performance is legitimate. "To say, is this an episode or is this a condition?" At the White House, "He had a cold and a bad night." spokesman Corinne Jean-Pierre spent nearly an hour fielding questions about the President's performance and mental state. "I'm not going to discount what the American people see or feel." and says he'll make his case straight to them. He will meet this week with Democratic lawmakers and governors. Do a network TV interview. Visit two states and hold a press conference. "We want to turn the page on this." Sagar Magani Washington. Two Russian naval ships have docked in Venezuela after exercises in the Atlantic Ocean. Moscow says they're there to "show the flag" in remote important regions. Russian President Putin and Chinese President Xi Jinping will meet Thursday as they travel to Kazakhstan in the summit of a group founded to counter Western alliances. This is AP News. There's a new Alzheimer's drug. The Food and Drug Administration approved a second Alzheimer's drug. It's made by Eli Lilly and is called Cassonla and is for mild or early cases of dementia caused by Alzheimer's. Cassonla is only the second drug that's been convincingly shown to delay cognitive decline in patients. Last year, a similar drug from Japanese drug maker ASI was approved. Doctors who treat Alzheimer's say approval is an important step after decades of failed experimental treatments. Patients and their families will have to weigh the benefits against the downsides, including regular IV infusions and potentially dangerous side effects like brain swelling. Questions remain about which patients should get the drugs and how long they might benefit. Ed Donahue Washington. The Dow gained 162 points yesterday. The S&P rose 33 points. The NASDAQ climbed 149 points. I'm Rita Foley, AP News.